BridgeBio Pharma Inc

BBIO

Market Cap$5.81B

Close$

Compare BridgeBio Pharma

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
BridgeBio Pharma Inc	-10.8	0%	51%	30.1	-1.6
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$50.00

Target Price by Analysts

66.2% upsideBridgeBio Pharma Target Price Details

$-9.00

Current Fair Value

129.9% downside

Overvalued by 129.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$5.81 Billion
Enterprise Value	$7.00 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-3.18
Beta	2.08
Outstanding Shares	187,129,260
Avg 30 Day Volume	1,513,165

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-10.79
PEG	14.41
Price to Sales	30.09
Price to Book Ratio	-5.02
Enterprise Value to Revenue	32.04
Enterprise Value to EBIT	-14.81
Enterprise Value to Net Income	-14
Total Debt to Enterprise	0.24
Debt to Equity	-1.63

Revenue Sources

No data

ESG Score

No data

About BridgeBio Pharma Inc

CEO: Neil Kumar